Title
Research for drug discovery and elucidation of pathophysiology using disease-specific iPS cells
Research overview
Aims: To address how status of KRAS in iPS cells impacts upon self-renewal and differentiation propensity
Methods: Roles of KRAS on stemness were investigated in the context of induced pluripotent stem cells (iPSCs). KRAS mutant (G13C/WT) and wild-type isogenic (WT/WT) iPSCs from a Ras-associated autoimmune leukoproliferative disorder (RALD) patient were used. Retention of self-renewal and capacity for neuronal differentiation were compared.
Targets: A RALD patient-derived iPSC clones (one with KRAS G13C mutation and the other one with no mutation derived from the same patient).
